Polymorphism | Oligonucleotide primers | Amplicone | Restriction endonucleases | Restriction products, b.p.* |
---|---|---|---|---|
CYP3A5*3 (intron 3) | f 5'-catcagttagtagacagatga-3' | 293 | Ssp I | 148 125 20 |
r 5'-ggtccaaacagggaagaaata-3' | (168 125) | |||
CYP3A4*1B (5'-NTR) | f 5'-tccaggcataggtaaagatc-3' | 111 | Acc 36 I | 111 |
r 5'-aatctattaaatcgcctctcac-3' | (85 26) | |||
CYP3A4*2 (exon 6) | f 5'-ttttttggatccattctttgtc-3' | 124 | Bst MA I | 98 26 |
r 5'-ttttaagtggatgaattacatggt-3' | (124) | |||
CYP2C9*2 (exon 3) | f 5'-cactggctgaaagagctaacagag-3' | 372 | Asp S9 I | 179 119 74 |
r 5'-gtgatatggagtagggtcacccac-3' | (253 119) | |||
CYP2C9*3 (exon 7) | f 5'-aggaagagattgaacgtgtga-3' | 130 | ERh I | 130 |
r 5'-ggcaggctggtggggagaaggccaa-3' | (104 26) | |||
CYP2C19*2 (exon 5) | f 5'-ccagagcttggcatattgta-3' | 230 | Sma I | 109 121 |
r 5'-gaagcaatcaataaagtcccga-3' | (230) | |||
CYP2C19*3 (exon 4) | f 5'-ctgggctgtgctccct-3' | 147 | BamH I | 128 19 |
r 5'-acttggccttacctggct-3' | (147) | |||
CYB2B6*5 (exon 9) | f 5'-aatacccccaacataccacatc-3' | 121 | Bst F5 I | 105 16 |
r 5'-gcggggagtcagagccatt-3' | (121) | |||
CYP2C8*2 (exon 5) | f 5’-aaagtaaaagaacaccaagc-3’ | 167 | Kzo9 I | 69 65 33 |
r 5’- aaacatccttagtaaattaca-3’ | (98 69) | |||
CYP2C8*3 (exon 3/8) | f 5’- aggcaattccccaatatctc-3’ | 467 | BseR I | 310 111 46 |
r 5’-caggatgcgcaatgaagac-3’ | (356 111) |